EPISODE · Apr 15, 2022 · 22 MIN
In conversation with... Eva Feldman
from Listen to The Lancet Neurology · host The Lancet
Eva Feldman (University of Michigan, Ann Arbor, USA) discusses the latest advances in the genetics, risk factors, pathophysiology, therapeutic development, and the diagnosis and prognosis of amyotrophic lateral sclerosis; the Series is published in the May issue of The Lancet Neurology.
NOW PLAYING
In conversation with... Eva Feldman
0:00
22:43
1×
No transcript for this episode yet
Similar Episodes
No similar episodes found.
Similar Podcasts
No similar podcasts found.
Frequently Asked Questions
How long is this episode of Listen to The Lancet Neurology?
This episode is 22 minutes long.
When was this Listen to The Lancet Neurology episode published?
This episode was published on April 15, 2022.
What is this episode about?
Eva Feldman (University of Michigan, Ann Arbor, USA) discusses the latest advances in the genetics, risk factors, pathophysiology, therapeutic development, and the diagnosis and prognosis of amyotrophic lateral sclerosis; the Series is published in...
Can I download this Listen to The Lancet Neurology episode?
Yes, you can download this episode by clicking the download button on the episode player, or subscribe to the podcast in your preferred podcast app for automatic downloads.
URL copied to clipboard!